PDE Inhibitors Market: Introduction
- Phosphodiesterase (PDE) inhibitors are therapeutic agents that target PDE isoenzymes and hinder the metabolism of the secondary messengers (cyclic adenosine monophosphate, cyclic guanosine monophosphate), thereby prolonging the biological effect determined by the type of cell involved. Selective and non-selective PDE inhibitors are being discovered as possible treatments for various indications such as Alzheimer’s disease, chronic obstructive pulmonary disease (COPD), and other ailments. Phosphodiesterase super family is complex, large, and represents 11 gene families from phosphodiesterase 1 to phosphodiesterase 11. Each of the phosphodiesterase families contains one or four genes. The phosphodiesterase are found in plasma membranes, cytosol, nuclear membranes, endoplasmic reticulum, and cytoskeleton.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=71364
Key Drivers and Opportunities of Global PDE Inhibitors Market
- Phosphodiesterase type 5 (PDE5) inhibitors are a group of medications most commonly used to treat erectile dysfunction. PDE5 inhibitors block PDE5, an enzyme in the walls of blood vessels. Hence, rise in prevalence of erectile dysfunction is projected to boost the growth of market. Prevalence of erectile dysfunction is the highest among men with diabetes and hypertension. According to the World Health Organization, about 150 million people have been affected by erectile dysfunction across the global and the number is projected to reach 230 million by 2025. It is a common medical condition affecting about 15% of men each year.
- Increase in unmet needs in the pharmaceutical industry contribute to development of PDE inhibitor products. Hence, key players focus on investment in research & development. This in turn is anticipated to drive the global market. For instance, Adamis Pharmaceuticals Corporation announced that it has been conducting pre-IND development for tadalafil to treat erectile dysfunction.
Request COVID Analysis on PDE Inhibitors Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=71364
- Strategies adopted by leading players to strengthen market position is expected to propel the global market. For instance, in September 2020, Aspargo Laboratories, Inc. acquired the international rights to Sildenafil oral spray for the treatment of erectile dysfunction.
- Governments of developing countries focus on improving health care infrastructure, and thereby increase access to pharmaceutical products. This is likely to create significant opportunities in the market.
North America to Dominate Global PDE Inhibitors Market
- In terms of region, the global PDE inhibitors market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global PDE inhibitors market during the forecast period. Well-established health care infrastructure and presence of key players are likely to augment the market in the region.
- The PDE inhibitors market in Asia Pacific is expected to grow at a rapid pace during the forecast period. Increase in awareness about the disease and treatment is likely to boost the growth of the market in the region.
Pre Book PDE Inhibitors Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=71364<ype=S
Key Players Operating in Global PDE Inhibitors Market
The global PDE inhibitors market is fragmented due to the presence of international as well as local players. A large number of manufacturers hold major share in their respective regions.
Key players operating in the global PDE inhibitors market are:
- Metuchen Pharmaceuticals, LLC
- Viatris, Inc.
- Eli Lilly and Company
- Bayer AG
- Pfizer, Inc.
- GlaxoSmithKline
- VIVUS
- Adamis Pharmaceuticals
- Aspargo Laboratories, Inc.
- Sandoz International GmbH
- Abbott
- Takeda Pharmaceutical Company Limited
- Boehringer Ingelheim International GmbH
Trending Reports of Transparency Market Research –
Smart Inhalers Market –
Medical Nonwoven Disposables Market –
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com
